HCW Biologics Inc. (HCWB) announced its Board of Directors has approved a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. This action is intended to ensure the company remains in compliance with The Nasdaq Capital Market's minimum bid price requirement of $1.00 per share and to avoid potential delisting.

Key Details

  • Ratio: One new share of common stock will be issued for every six existing shares.
  • Effective Date: The reverse stock split will be effective at 12:01 a.m. ET on June 30, 2026, with split-adjusted trading beginning at market open on the same day.
  • Impact on Shares: The number of outstanding shares will be reduced from approximately 9.58 million to approximately 1.6 million. The number of authorized shares will remain unchanged at 250 million.
  • Trading Symbol: The company's stock will continue to trade on Nasdaq under the symbol "HCWB" but with a new CUSIP number (40423R303).